| Target Price | ¥1,224.00 |
| Price | ¥1,078.00 |
| Potential |
13.54%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target H I S Co 2027 .
The average H I S Co target price is ¥1,224.00.
This is
13.54%
register free of charge
¥1,365.00
26.62%
register free of charge
¥1,090.80
1.19%
register free of charge
|
|
| A rating was issued by 9 analysts: 4 Analysts recommend H I S Co to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the H I S Co stock has an average upside potential 2027 of
13.54%
register free of charge
|
| Oct '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | 373.11 | 408.87 |
| 8.67% | 9.58% | |
| EBITDA Margin | 5.55% | 5.53% |
| 2.89% | 0.34% | |
| Net Margin | 1.26% | 0.13% |
| 50.18% | 89.72% |
6 Analysts have issued a sales forecast H I S Co 2026 . The average H I S Co sales estimate is
This results in the following potential growth metrics:
4 Analysts have issued an H I S Co EBITDA forecast 2026. The average H I S Co EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 H I S Co Analysts have issued a net profit forecast 2026. The average H I S Co net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Oct '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | 62.99 | 6.87 |
| 42.63% | 89.09% | |
| P/E | 156.43 | |
| EV/Sales | 0.39 |
6 Analysts have issued a H I S Co forecast for earnings per share. The average H I S Co EPS is
This results in the following potential growth metrics and future valuations:
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


